Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Registry following adults newly diagnosed with heart failure and reduced heart pumping

Follows adults newly diagnosed with heart failure and reduced heart pumping over time.

Plain-language title generated from the registry record
Registry title: QUAD-HF - Prospective Registry of Patients With Incident Heart Failure and Left Ventricular Ejection Fraction <50%

Key facts

Where
Basildon and Glasgow, United KingdomSee the 2 sites

Where in United Kingdom

  • Mid and South Essex NHS Foundation TrustBasildon, United KingdomTaking people
  • British Heart Foundation Glasgow Cardiovascular Research Centre, GlasgowGlasgow, United KingdomNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Mid and South Essex NHS Foundation Trust
Trial code
NCT07174362
Record updated
16 December 2025
Original description
The QUAD-HF registry is an observational study that would enroll patients in the United Kingdom, who have been newly diagnosed with heart failure and a left ventricular ejection fraction <50%. We plan to assess clinical outcomes in these patients, such as hospitalization and death, in relation to their diagnosis, implementation of guidelines and type of treatments these patients have received.Read full original descriptionShow less

QUAD-HF Registry - A Prospective Registry of Patients With Incident Heart Failure and Left Ventricular Ejection Fraction of <50%

The QUAD-HF registry is an observational study that would enroll patients in the United Kingdom, who have been newly diagnosed with heart failure and a left ventricular ejection fraction <50%. We plan to assess clinical outcomes in these patients, such as hospitalization and death, in relation to their diagnosis, implementation of guidelines and type of treatments these patients have received.

Inclusion: Age >18 years; Newly diagnosed Heart Failure with a Left Ventricular Ejection Fraction <50% (≤12 Weeks prior to enrolment); Able and willing to consent.

Exclusion: LVEF 50% or more at time of diagnosis; Palliative care; Unable or unwilling to give consent.

ClinicalTrials.gov NCT07174362